Evidence map›Paper›PMID 26525001›Full record

ArticleThe World Allergy Organization journal2015

2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines.

F Estelle R Simons, Motohiro Ebisawa, Mario Sanchez-Borges, Bernard Y Thong, Margitta Worm, Luciana Kase Tanno, Richard F Lockey, Yehia M El-Gamal, Simon Ga Brown, Hae-Sim Park and 1 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The World Allergy Organization journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04755881 (SHARED), which is not on this map. Cited by 156 papers.

0numbers the graph read from it
0cells of the map it votes in
156citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04755881 terminatednot on this mapstarted 2019, after this paper: background citation

SHARED (Saguenay Hospitals Anaphylaxis Rule for Early Discharge) - Phase 2 : a Prospective Theoretical Validation

Typeobservational_patient_registrySponsorUniversité de SherbrookeRan2019 to 2023Enrolled191ConditionsAnaphylaxis, Biphasic Anaphylactic Reaction, Rebound Anaphylactic ReactionArmsOccurence of biphasic reaction following anaphylaxis
3 · Its place in the literature

Who cites it

156 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Anaphylaxis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Article

96 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

F Estelle R SimonsDepartment of Pediatrics & Child Health and Department of Immunology, College of Medicine, Faculty of Health Sciences, The University of Manitoba, Room FE125, 820 Sherbrook Street, Winnipeg, R3A 1R9 MB Canada.
Motohiro EbisawaDepartment of Allergy, Clinical Research Center for Allergy & Rheumatology, Sagamihara National Hospital, Sagamihara, Kanagawa Japan.
Mario Sanchez-BorgesAllergy and Clinical Immunology Department, Centro Medico-Docente La Trinidad, Caracas, Venezuela.
Bernard Y ThongDepartment of Rheumatology, Allergy & Immunology, Tan Tock Seng Hospital, Singapore, Singapore.
Margitta WormAllergie-Centrum-Charite, Klinik fur Dermatologie, Venerologie und Allergologie, Campus Charite Mitte, Universitatsmedizin, Berlin, Germany.
Luciana Kase TannoDepartment of Allergy and Clinical Immunology, Hospital Servidor Publico Estadual de Sao Paulo and Hospital Sirio-Libanes, Sao Paulo, Brazil.
Richard F LockeyUniversity of South Florida College of Medicine, Tampa, FL USA.
Yehia M El-GamalPediatric Allergy and Immunology Unit, Children's Hospital, Ain Shams University, Cairo, Egypt.
Simon Ga BrownRoyal Hobart Hospital, Tasmania, and University of Western Australia and Royal Perth Hospital, Perth, Western Australia.
Hae-Sim ParkDepartment of Allergy & Clinical Immunology, Ajou University School of Medicine, Seoul, South Korea.
Aziz SheikhAllergy & Respiratory Research Group, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Allergy Organization (WAO) Guidelines for the assessment and management of anaphylaxis provide a unique global perspective on this increasingly common, potentially life-threatening disease. Recommendations made in the original WAO Anaphylaxis Guidelines remain clinically valid and relevant, and are a widely accessed and frequently cited resource. In this 2015 update of the evidence supporting recommendations in the Guidelines, new information based on anaphylaxis publications from January 2014 through mid- 2015 is summarized. Advances in epidemiology, diagnosis, and management in healthcare and community settings are highlighted. Additionally, new information about patient factors that increase the risk of severe and/or fatal anaphylaxis and patient co-factors that amplify anaphylactic episodes is presented and new information about anaphylaxis triggers and confirmation of triggers to facilitate specific trigger avoidance and immunomodulation is reviewed. The update includes tables summarizing important advances in anaphylaxis research.

Indexed as

AdrenalineAnaphylaxisAuto-injectorDrug allergyEpinephrineExercise-induced anaphylaxisFood allergyLatex allergyStinging insect venom allergySystemic allergic reaction

Identifiers

PMID26525001
PMCPMC4625730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.